Psoas muscle mass in patients undergoing lung cancer surgery: a prognostic difference between squamous cell carcinoma and adenocarcinoma.
Naoki OzekiKoji KawaguchiTakayuki FukuiShota NakamuraShuhei HakiriShunsuke MoriMasaki GotoShingo IwanoKohei YokoiToyofumi Fengshi Chen-YoshikawaPublished in: International journal of clinical oncology (2020)
The PMI was significantly associated with the survival of lung SCC patients, but not of lung ADC patients, suggesting the presence of a previously unidentified relationship between skeletal muscle and lung SCC progression.
Keyphrases
- squamous cell carcinoma
- end stage renal disease
- skeletal muscle
- patients undergoing
- newly diagnosed
- ejection fraction
- prognostic factors
- minimally invasive
- peritoneal dialysis
- magnetic resonance imaging
- type diabetes
- metabolic syndrome
- radiation therapy
- magnetic resonance
- patient reported outcomes
- coronary artery disease
- acute coronary syndrome
- atrial fibrillation